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This paper investigates the influence of human resource management practices on the likelihood 
that a firm performs in-house R&D. The latter is broadly interpreted as learning---a mechanism 
promoting absorptive capacity and supporting technology capability-building in latecomer 
firms. The use of distinct definitions of R&D implies different knowledge requirements that 
firms need to fulfil in order to innovate. The analysis assumes that firms can choose between 
two learning strategies: they may exploit existing knowledge, or perform more complex 
explorations and acquire new knowledge. Different knowledge requirements, in turn, underpin 
distinct R&D outcomes with varying degrees of novelty, at least for the firm. Unlike the 
recurrent interest in recent catching up experiences of countries, such as India, findings in this 
paper are supported with evidence from the pharmaceutical industry in Mexico. The analysis 
reveals some linkages between management practices and learning at firm level. Such influence 
increases with the novelty of the knowledge required by the firm. Learning to improve or 
enhance generic drugs is somewhat more demanding than imitative R&D. 
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Literature on the linkages between human resource management practices and innovation 
performance at firm level is increasing. Scholars have addressed the extent to which sets of new 
and dynamic work practices influence innovation (OECD, 1998; Barton and Delbridge, 2001), 
the effects of distinct forms of labour flexibility on innovation performance (Michie and 
Sheehan, 1999, 2003), and even the complementary relationships that exist between 
management practices underpinning innovation (Delery, 1998; Laursen and Foss, 2003). 
Research on the organization and learning of agents involved in the development of new 
products is likewise increasing (Lund, 2004a, b). Studies based on evidence on developed 
countries (Lorenz and Wilkinson, 2003; Arundel et al., 2007), investigate how the influence of 
management practices varies depending on the technological dynamics of different industries 
(Laursen, 2002; Laursen and Foss, 2003; Terziovski and Morgan, 2006). These strands of 
literature document the positive relationships between management practices and innovation 
performance at firm level. What is still missing, however, is a better understanding of 
mechanisms to explain such relationships (Laursen and Foss, 2003; Lorenz and Wilkinson, 
2003), and a consistent theory on what Delery (1998) terms the “transmission mechanism” from 
management to innovation performance. 
 
Explaining how and why management practices underpin innovation introduce innovation 
scholars into the more ample debate of how and why such practices influence firms’ 
performance more generally. According to Boseli et al. (2005) and Combs et al. (2006) huge 
challenges stem from the diversity in the number and possible definitions of indicators on 
management practices, together with the distinct multidisciplinary approaches to research. 
Arguably, research on management practices and innovation need to be fine-tuned, specifically 
in the way the issues at stake. Lorenz and Wilkinson (2003) assert that researchers frequently 
assume linear relationships---from adoption of specific sets of management practices to 
innovation, leaving little room for more heterogeneous organizational strategies within single 
industries (Delery 1998; Hemmert and Oberländer 1998). It is customary to look at innovation 
outcomes---products/processes, and their degrees of novelty---radical/incremental. Equally 
understimated is the study of some latent processes associated with the organization of people 
involved in innovation. It seems pertinent to look at the cumulative learning processes 
supporting the development of innovation capabilities by individuals and, ultimately, 
organizations (Cohen and Levinthal 1989,1990; March 1991; Grant 1996). Management 
practices become mechanisms that influence learning within organizations (Wright et al. 2001).  
 
Focusing attention on learning processes would give research greater relevance from a 
development perspective. White (2002) points out the pertinence to understand how 
management practices contribute to research and other technological capabilities, particularly in 
developing countries. Accumulated capacities can erode because of inadequate or poor 
management of people. Research on firms in developing countries similarly necessitates a 
careful understanding of the nature of the innovation and learning activities they engage in. 
 
This paper attempts to contribute to existing literature on human resource management practices 
and learning in the context of developing countries. Here, empirical evidence refers to 
pharmaceutical firms in Mexico. The paper proceeds as follows: Section 2 discusses the 
literature linking management practices, learning and catching-up processes of firms in 
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latecomer countries. Based on notions of knowledge exploration and exploitation, the paper 
investigates the influence of management practices on the likelihood that a firm engages in in-
house research and development (R&D). The latter is broadly interpreted as learning, and is 
distinguished according to several objectives pursued by the firm,1 irrespective of whether they 
relate to improved or new products or process innovations. Against this background, section 3 
characterizes some management practices expected to enhance individuals', and consequently 
organizational, learning. The discussion proposes the testing of several hypotheses during the 
empirical analysis. Section 4 presents the data, and defines variables and the corresponding 
research strategy. Results are provided in section 5, while a discussion of the same is presented 
in section 6. Section 7 concludes. 
 
2. Management practices, learning and R&D in latecomer firms 
 
Empirical literature documents the contribution that organizational practices, relating to R&D 
and innovation, have made toward the catching-up processes of latecomer firms. Successful 
firms have evolved as learners by assimilating and tapping existing technologies, and eventually 
developing their capacity to generate their own technologies (Hobday et al. 2004). Catching-up 
involves continuous efforts to mobilize and organize resources that firms have at hand. In the 
case of Japan, for example, Odagiri (1998) highlighted the importance of building the 
absorptive capabilities, making efforts in training and entrepreneurship and gaining a sound 
scientific and technological understanding, including mastering the production and management 
of skilled personnel. Hemmert (1998) further underscores such factors in his analysis of how 
Japanese firms have dealt with changing, often adverse, macroeconomic environments, and the 
challenges associated with business strategies posed by continuous technological innovation. 
Firms have had to constantly reorganize and restructure their R&D activities in general, and the 
management of R&D personnel in particular. Continuous improvement in personnel 
management has underpinned innovative organizational practices to promote incentives, 
motivation and productivity and attract R&D –Legewie et al. (2000). Accordingly, (Hemmert 
1998) and more recently Michie and Sheehan (1999,2003) call for further investigation of the 
relationship between management practices and firms’ capacity to engage in R&D. In a similar 
vein, Lundvall et al. (2002) argue that in addition to R&D efforts, analyses of firms’ innovation 
capabilities need to consider the influence emanating from the daily experiences of workers, 
engineers and salesmen, together with interactions among individuals within and outside the 
boundaries of a firm. 
 
Cohen and Levinthal (1989, 1990) treatment of the dual role of R&D as a learning mechanism 
traces a link between management practices and R&D. R&D generates new information and 
knowledge underpinning searches for new market and technological opportunities through 
innovation. R&D is equally relevant for assimilating and exploiting existing information and 
knowledge. In other words, it helps to build the absorptive capacity by tapping existing 
knowledge. Cohen and Levinthal (1989, 1990) stressed that the contribution of individuals’ 
cognitive processes to accumulate absorptive capacity is contingent on the nature of prior 
related knowledge and diversity of backgrounds. These elements depend on an individual’s 
capacity to absorb, assimilate, link, analyze and, eventually, create knowledge. The authors 
                                                 
1 In the interest of the extent and feasibility of the analysis, the focus here is on technological efforts only 




further distinguished between expected goals from R&D. Firms may exploit their existing 
knowledge bases, or engage in knowledge exploration and expansion of knowledge bases. From 
a management perspective, the notions of knowledge exploitation and exploration, as central 
and distinguishable elements shaping organizational learning and capability-building, are 
integrated in the so-called knowledge-based theory of the firm (March 1991). According to this 
literature, the primary role of firms, which is the basis of organizational capabilities, is the 
integration of specialized knowledge (Grant 1996). The latter in turn, is often perceived in tacit 
form, and know-how, skills and practical knowledge embedded in individuals who are 
considered core components of an organization (Barney 1991). Management interventions 
influence the organization and mobilization of individuals and their corresponding knowledge 
(Cohen and Levinthal 1989, 1990; Barney 1991).  
 
That firms engage in either knowledge exploitation or exploration activities, or both, illustrates 
the heterogeneity, complexity and distinct use of knowledge. Exploitation refers to the use and 
refinement of existing knowledge, technologies and products. It entails short-run perspectives, 
more certainty and proximity to potential benefits. Exploration, for its part, identifies searches 
for new knowledge, use of unfamiliar technologies, creation of products/services with 
unforeseen, or, at least, difficult to predict, demand (March 1991; Greve 2007). Exploration also 
implies long-run mindset, greater uncertainty about future revenues and benefits. Although, 
exploration and exploitation have potentially reinforcing effects on learning and capability-
building, they lead to competing resource allocation, increased risks and tradeoffs in investment 
decisions. Finding the right balance is problematic, the choice of either strategy depends on the 
survival and prosperity of firms: “...Systems that engage in exploration to the exclusion of 
exploitation are likely to find that they suffer the costs of experimentation without gaining many 
of its benefits. They exhibit too many undeveloped new ideas and too little distinctive 
competence. Conversely, systems that engage in exploitation to the exclusion of exploration are 
likely to find themselves trapped in suboptimal stable equilibria” (March 1991:71). 
 
From the above, and based on Li et al. (2008), a practical interpretation of exploration and 
exploitation activities is in terms of the cognitive distance between knowledge requirements and 
a firm's knowledge base. The latter in turn, is characterized by Kale and Little (2007:594) “as 
simple and complex, based on the technological challenges involved in developing particular 
products and underlaying capabilities”. Exploitation refers to local searches for familiar, mature, 
current or proximate knowledge; it builds on existing technological capabilities. By contrast, 
exploration underpins searches for unfamiliar, distant knowledge. This interpretation induces 
some flexibility to the analysis while still capturing traditional views of innovation in terms of 
incremental and radical outcomes (Greve 2007). Whereas local searches may lead to 
incremental innovations, distant searches could lead to radical ones. Nevertheless, there is no a 
priori reason for such a match to occur.  
 
The proposed interpretation is in line with empirical literature. Rather than focusing on 
innovation itself, attention is drawn to the learning process inside the firm. Successful catching-
up experiences have coupled local searches, through internal learning efforts, with a few distant 
searches, knowledge diffusion and assimilation through, for instance, reverse engineering 
activities. Firms combine stocks and flows of knowledge. Only when latecomer firms start to 
approach the technological frontier, does high quality basic research, more complex scientific 
techniques and instrumentation progressively gain importance to sustain productivity and 
competitiveness (Patel and Pavitt 1994). However, the transition from technology-follower 
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status to that of technology-leadership is neither linear nor automatic. Hobday et al. (2004) 
suggest that the transition requires, as complementary assets, gaining international brand 
recognition, strong marketing capabilities and control over foreign distribution channels, 
together with the ability to carry out the necessary organizational and structural changes. 
 
2.1. An example from the pharmaceutical industry 
 
The pharmaceutical industry is illustrative of the issues discused above. Based on a capability 
building model, Kale and Little (2007) argue that “reverse engineering R&D capability –the 
ability to develop products by copying the process-is categorised as a basic capability. Generics 
R&D involves incremental change representing intermediate capability while new chemical 
entity research involves creating new drugs and innovative therapies representing advanced 
capabilities” (p.594). Building on the recent experience of Indian pharmaceutical firms, the 
authors illustrate how each stage of capability accumulation makes different demands from a 
firm’s knowledge base. Over time, local firms use, acquire and accumulate different types of 
knowledge inputs for innovation with increasing degrees of novelty. Progression in the 
technology ladder has accompanied the expansion of learning activities outside familiar 
cognitive boundaries; knowledge searches have become increasingly exploratory. Knowledge 
exploitation, however, remains relevant particularly for firms whose business strategies are still 
based on the extension of life-cycles of existing pharmaceutical products. This experience, 
together with those presented by Cardinal and Hatfield (2000) and Kim (1997) for example, 
show that although the technological dynamism of firms in catching up modes generally lags 
behind that of large multinationals, R&D remains core ingredient for success. The major 
difference is that, in most cases, R&D in developing countries leads to incremental innovations.  
 
Development of generics starts a few years before patent expiry of the innovator product. Firms 
have to reproduce the knowledge needed to manufacture it while ensuring bioequivalence and 
biodisponibility, thus supporting its characteristic as a generic interchangeable drug2. Speed is 
necessary, to the extent that first movers can gain and retain relevant market shares (Caves et al. 
1991; Hollis 2002). In most cases, the choice of products is linked to current product portfolios; 
what firms already know. Nevertheless, expected benefits increase if firms are able to enhance 
the characteristics of the innovator drug. Quality enhancement includes relatively simple 
improvements in product packaging, reformulation or recombinition of existing molecules. New 
products, in turn, include new applications of existing drugs, often in different therapeutic areas. 
The search for new knowledge may relate more to the methods and techniques used to 
synthesize the components---biotechnology techniques, for instance---than to the characteristics 
of the drug itself (Kale and Little 2007).  
 
The mix of current and new knowledge, relative to the firm’s knowledge base, remains central 
for the analysis. In this context, Kim and Cha (2000) and Laursen and Foss (2003) contend that 
firms with different technological profiles require and mobilize resources differently. More 
heterogenous organizational models, as compared with those in mainstream literature, are 
possible. Dávila and Elvira (2007) for instance, stress culture, context and history as inducing a 
different, yet functional, form of employer-employee interaction. Equally pertinent is the 
increasing importance of the character of innovation and the frequent dearth of formal R&D 
                                                 
2 Generic interchangeable (GI) denomination indicates that the reaction to a generic drug in the human 
body is exactly the same as that of an innovator drug. 
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units within latecomer firms (Santamaría et al. 2009). All this widens the gap between 
traditional studies on management practices in manufacturing and those on formal R&D 
departments. Based on data on the pharmaceutical industry in Mexico, the world’s ninth 
pharmaceutical market and the second in Latin America, this paper endeavours to shed light on 
some of the issues involved. 
 
3. Management practices and learning through R&D: Mexican pharmaceuticals 
 
Section 1 commented on the complexities to define, based on widely accepted theoretical 
rationale, comprehensive checklists of management practices determining performance at firm 
level. Boseli et al. (2005) and Combs et al. (2006 advise pragmatism in approaches to research, 
claiming that it should build on a mix of theory, previous empirical evidence, intuition and a 
careful look at existing data. In this regard, enhanced organizational practices frequently relate 
to Japanese management styles. Hemmert (1998) for example, indicated practices targeting 
R&D personnel including: hiring and firing, job rotation and continuity and compensation 
systems. Literature on complementarities identifies sets of interventions explaining distinct 
productive and innovative performance (Ichniowski et al. 1997; Michie and Sheehan 1999; 
Laursen and Foss 2003; Michie and Sheehan 2003). These sets include indicators on labour 
relations---incentives and compensation, recruitment and selection, teamwork, employment 
security, flexibility in job assignments, training, labour-management communication, grievance 
rates and so on.  
 
Literature on developing countries identifies practices accompanying the adoption of 
organizational techniques, such as total quality management (TQM) or just-in-time (JIT), 
including the provision of training, workers’ empowerment, payment and staff promotion (Tello 
and Greene 1996; Abramo 1997; Islas 2003; Vargas 2004). Additional information was 
obtained through exploratory interviews with some 20 multinational and Mexican 
pharmaceutical firms. In general, firms were affiliated to the main local trade organization---
Cámara Nacional de la Industria Farmacéutica (CANIFARMA). The goal was to learn about 
the nature of innovation activities, R&D, and the associated management practices in the local 





Training underpins development of technical and managerial skills among people, who are 
repositories of the tacit knowledge of an organization (Johnson et al. 1996). Tacit knowledge 
supports organizational structures, as well as the productive and innovation capabilities of a 
firm. Training takes two complementary forms: on-the-job and off-the-job. The former is most 
common. It supports learning of day-to-day operations and an understanding of basic concepts. 
The second, usually available for key personnel, contributes to enhancing the intellectual capital 
and skills by capturing existing knowledge, that is, latest developments in specific knowledge 
fields, research techniques and so on (Hara 2003). Training contributes to strategies that can be 
devised to promote motivation and reward human resources. However Gray et al. (2004) stress 
that the influence of training depends very much on the creation of an environment where 
sufficient returns can be expected. In other words, it needs to be accompanied by pertinent 
incentives and working conditions so that improved skills are adequately used (Laursen and 




Pharmaceutical firms in Mexico show great propensity to provide training to employees–Annex 
3. This is more frequent in the case of knowledge exploitation. In general, firms combine 
internal and external sources of training, in an effort to capture the synergistic effects between 
the two types of training. The local industry reproduces the behaviour observed at global level. 
Pharmaceuticals firms are strongly inclined to train personnel across operations (Bureau of 
Labor Statistics 2007). Training requirements range from a few hours of on-the-job training to 
years of formal education, including job experience. Training not only includes development of 
general skills, but also those needed to carry out specific projects, develop particular processes, 
conduct specific analyses, handle specialized equipment and so on. Firms frequently train in 
safety, environmental and quality control and technological advances. Training in marketing 
and sales is expected to increase the market success of a product. From the above, it could be 
expected that the provision of training would have a positive influence on the likelihood that 




Adequate compensation and reward for performance are expected to positively and significantly 
impact on learning and innovation (Badawy 1988). Appreciation of individual and professional 
aspirations promotes motivation and commitment towards an organization (Mumford 2000; 
Quinn and Rubb 2006). Effective reward systems encourage employees to take risks, pursue the 
development of new products and continuously generate ideas that can be realized (Mumford 
2000). Creativity can be encouraged if freedom, financial rewards, promotion and other forms 
of recognition exist (Amabile 1997).  
 
Remunerations contribute to skill development cycles (Samstad and Pipkin 2005); they may 
strategically attract talent from outsied thereby minimizing costs of internal training (Labarca 
1999). Setting adequate remuneration systems is complex. More importantly, creative 
individuals may prefer a challenging and innovation-driven environment over high salaries. For 
instance, Terziovski and Morgan (2006) argue that in science-based industries, such as 
biotechnology, performance-linked rewards might not be as attractive and stimulating as 
compared to access to sophisticated scientific equipment and instruments enabling researchers 
to work while increasing their intellectual capacity. The ENESTYC documents that in Mexico, 
remunerations in the pharmaceutical industry are higher than in other manufacturing industries. 
They are even higher in firms performing in-house R&D. As a mechanism to motivate and 
retain workers, remunerations are frequently limited to adjustment without altering the firm’s 
structure of compensations as a whole. These considerations lead us to expect remunerations to 




Self-esteem---the feeling of power---is an important determinant of employee performance 
(Gupta and Singhal 1993). Empowering employees is basic for high-performance work systems 
(Bartlett et al. 2002), it provides people the opportunity and means to tackle new problems, they 
gain varied experiences, and are prepared to take on more challenging tasks. People may 
participate in the definition of their personal objectives, the time they spend at work. They 
would voluntarily request to be involved in assignments promoting skills development, or in the 
establishment and management of effective mentoring relationships and so on (Hemmert 1998; 
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Laursen and Foss 2003; Michie and Sheehan 2003). In such a way firms may foster discovery 
activities (OECD 1998; Mumford 2000). However Bartlett et al. (2002) warn that mismatches 
between increased responsibility, and means and skills to perform the job could render 
empowerment meaningless, even counterproductive. Successful empowerment is often 
associated with teamwork, training and other practices (Carrillo and Ramírez 1997; García 
2002).  
 
Workers in the Mexican pharmaceutical industry face limited opportunities to participate in 
decision-making on the working conditions, and whenever that happens, it is of limited 
relevance to the firm. In this regard, it must be acknowledged that strict regulations faced by the 
industry may reduce opportunities to modify the working conditions. In fact, these are already 
among the best throughout manufacturing activities. Manufacturing processes and operations, in 
general, must comply with strict current good manufacturing practices3 and other industry 
standards, and work closely with regulatory authorities. Regarding R&D, the literature 
documents that drug development activities, such as those underpinning the formulation of 
generic drugs, may be more structured and defined in terms of timing, nature of tasks, formality 
in the organization, conduction of activities, and so on. Exploratory interviews with the local 
industry revealed that R&D staff may frequently succumb to the needs of manufacturing and 
quality control departments. The expectation is that workers’ empowerment would positively 
affect the probability of R&D performance. 
 
3.1.4. Rotation assignments 
 
Gupta and Singhal (1993) comment that innovative firms encourage employees to work in 
various departments and divisions, so that they can gain experience and a better understanding 
of operations, products and resources available at the firm. Rotation potentially increases 
knowledge-sharing and awareness of problems affecting different parts of the organization and, 
if at all present, its multi-faceted innovation processes (Laursen 2002). Rotation supports 
learning if participants are carefully selected and if practices are adequately timed and framed 
within specific skill development strategies (Mumford 2000). Relatively little evidence was 
found on the concrete use of rotational assignments in the Mexican pharmaceutical industry. In 
general, the practice was found to be relatively unimportant as a learning mechanism. Rather, 
and particularly, in firms with some formal R&D activities, it was frequently associated with 
staff hiring. The new employee would move around the laboratory, meet more senior staff, test 
and learn about the activities of the department. In light of this diverging evidence, concrete 
conclusions can be drawn from the empirical analysis. 
 
3.1.5. Hiring staff 
 
Badawy (1988) proposes that effective human resource planning is the key to innovation. This 
includes determining staffing needs, hiring qualified people according to job characteristics, 
                                                 
3 In most countries, sanitary authorities ensure effectiveness and safety of pharmaceutical products by 
implementing comprehensive safeguards and procedures of obligatory observance for drug 
manufacturers. These are summarized under good manufacturing practice (GMP) which, in simple terms, 
indicates the best rules/practices to manufacture drugs (FDA, 2004a; Seiter, 2005). GMPs include layout 
and functionality of buildings, qualification and training of personnel, cleanliness and sanitation, 
monitoring, supervision and many other aspects. GMP’s are reviewed and adjusted according to scientific 
and technological advances, hence the term “current” or cGMPs. 
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knowledge and skill competencies, as well as ensuring an appropriate mix of personnel during 
the innovation processes (Terziovski and Morgan 2006). Hiring helps to tap external knowledge 
in the interest of internal requirements (Du and Ai 2008; Santamaría et al. 2009). New staff 
should conform to predefined personality traits, knowledge background and experience; they 
should fit with existing teams and organizational dynamics. Particularly in managerial positions, 
potential for creativity and learning should accompany capacity to promote such behaviour 
among other staff members (Gupta and Singhal 1993). Staffing practices in developing 
countries are often constrained by whether firms seek blue-collar or better skilled white-collar 
personnel. For the first category of workers, the process appears relatively simple, given the 
traditionally low qualifications of local labour. It becomes more complicated when hiring staff 
for higher positions; availability of well trained and experienced people is scarce. Finding the 
right candidates for off-line positions requires strategic hiring, becomes more complicated and 
involves higher costs (Flynn 1994; Forest 1994). In this regard, Peña (2000) documents that in 
high turnover maquiladora contexts, hiring practices may focus more on compensating a 
worker’s lost, rather than acquiring new, talents. Here again empirical results could help to shed 
light on the impact that staff hiring has on internal learning strategies. 
 
3.1.6. Staff promotion 
 
Promotion policies and associated practices substantially affect professional perspectives. First 
steps in designing sound professional development programmes include diagnostics of career 
issues in the organization (Badawy 1988). Igbaria et al. (1999) mention that career development 
should focus on retaining and motivating workers by matching organizational and individual 
needs. Perspectives for professional advancement, ways to measure productivity in R&D, 
consideration of distinct professional aspirations and different backgrounds of scientists and 
engineers guarantees loyalty and willingness to carry out innovation. These groups of 
professionals may feel and react differently towards fairness and objectivity of career 
development systems (Tremblay et al. 2002). Additional elements derive from the balance 
between internal and external labour markets, whether firms hire for entry level jobs, while 
higher levels are filled from within; or if positions are filled by hiring outsiders at all levels 
(Lazear and Oyer 2004).  
 
With regard to staff promotion, multinational affiliates in Mexico tend to follow Japanese-like 
management approaches---favouring internal labour markets over external sources. Firms 
implement programmes on career development, including succession plans to enhance internal 
mobility. Employees, at least at mid-rank level, apply for a vacant position with the hope of 
being selected for the position, especially if it offers a promotion or affects turnover. By 
contrast, firms of Mexican origin showed very limited use of the practice. Smaller firm size or 
lack of specific plans to do so would explain this. Formalization of promotion mechanisms 
could have a positive impact on R&D. 
 
4. Data sources, variable definition and research strategy 
 
Data used in this paper were extracted from the Encuesta Nacional de Empleo, Salarios, 
Tecnología y Capacitación (ENESTyC). This survey was carried out by the Instituto Nacional 
de Estadística, Geografía e Informática (INEGI) on behalf of the Secretaría del Trabajo y 
Previsión Social (STPS), Mexico. ENESTYC represents the entire Mexican manufacturing 
sector. The manufacturing establishment constitutes the unit of analysis. The survey builds on a 
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stratified sample based on the establishment’s size, as measured by total employment: Large 
251+; medium: 101-250; small: 10-100 and micro: 0-5. Classification of activities is based on 
the North American Industrial Classification System (NASCI). establishments with 100 or more 
employees are included together with a random sample of those with less than 100 employees. 
The total number of manufacturing units is 9,920. Confidence level is 95 per cent, with an 
estimated non-response of 10 per cent.  
 
The latest available publication of ENESTYC corresponds to 2001. Nevertheless, based on an 
agreement to comply with pertinent confidentiality requirements by INEGI, personnel from this 
Institute processed the preliminary data based on information for 2004. ENESTYC provided 
information on technological and organizational profiles; employment and remuneration levels; 
management practices and the provision of training. The module for the pharmaceutical industry 
(NASCI code 3254) includes 141 data points, representing 388 establishments. The effective 
working sample, excluding missing values, is 112 data points, which is equivalent to some 308 
establishments. Due to the inability to match data points with specific firms, the remaining part 
of this paper uses, indistinctly, the terms establishment and firm. However, it must be pointed 
out that firms could own more than one establishment. 
 
4.1. Dependent variables  
 
ENESTYC provides information on R&D and the objectives of such activities (table 1). In the 
context of pharmaceutical firms, it identifies cost-reducing innovations through:  
 
1.  improvements in existing drug manufacturing processes  
2.  improvement or design of new machinery and equipment for the firm’s own use. This 
second is interpreted as R&D for new process innovation.  
 
Alternatively, R&D seeks demand-enhancing innovations including:  
3. quality improvements on existing pharmaceutical products  
4. design of new products.  
 
Based on the discussion in section 2, (1) and (3) above are interpreted as knowledge 
exploitation activities, improvement in pharmaceutical products and processes leads to searches 
within familiar knowledge bases. By contrast, the introduction of some new drugs or new 
manufacturing processes, indicators (2) and (4), relate to knowledege searches outside familiar 
cognitive, including physical and geographical, boundaries.4 This distinction coincides with 
Kale and Little’s (2007) differenciation of pharmaceutical firms, based on their accumulated 
technological capabilities. By combining (1) and (3) a variable on R&D for knowledge 
exploitation, rd_exploit is obtained. Likewise, by combining (2) and (4) the variable on R&D 
for knowledge exploration, rd_explore is obtained. In general, firms in Mexico pursue imitative 
and incremental innovations.   
 
                                                 
4Similar interpretations in the context of biotechnology and pharmaceuticals are found in Rothaermel and 




Table 1: Indicators on in-house R&D performance by pharmaceutical firms in Mexico  
Variable Definition Mean Std 
Dev 
Value 












2. rd_design_meq The goal of R&D is to improve or design new machinery and 
equipment for own use 
.187 .392 
3. rd_improve_process The goal of R&D is to improve existing manufacturing processes .634 .484 
4. rd_drug_design The goal of R&D is to design new pharmaceutical products .616 .488 
5. rd_drug_improvement The goal of R&D is to improve existing pharmaceutical products .661 .476 
6. rd_exploit The firm performs R&D for knowledge exploitation .714 .454 
7. rd_explore The firm performs R&D for knowledge exploration .625 .486 
Source: ENESTYC, 2005 
 
 
4.2. Explanatory variables 
 
Table 2: Management and control variables included in the analysis 
 Min Max Description 
train04 0 1 1 if the firm provided training to its employees in 2004; 0 otherwise 
training_internal 0 1 1 if training is provided by colleagues in-house; 0 otherwise 
external_training 0 1 1 if the firm provides training through external providers (specialized 
public job training centres, public universities, private universities, other 
firms, consultants or the industry’s trade organization); 0 otherwise 
internal_external_tr 0 1 1 if the firm provides training both in-house and externally; 0 otherwise. 
Interaction term between training_internal and external_training 
ln_avg_rem 2.674 5.749 Natural logarithm of the average remuneration per worker: total 
remuneration (salaries and benefits) paid in 2004 divided by total number 
of employees in that same year 
imp_empowerment 0 2 1 if workers participate in decision making and the firm declares that 
such practice is important; 2 not important; 0 workers do not participate  
rule_promotion 0 1 1 if the firm regulates staff promotion through either collective contracts 
or other internal negotiations; 0 otherwise  
rule_hiring 0 1 1 if the firm regulates hiring staff through either collective contracts or 
other internal negotiations; 0 otherwise  
rule_temprot 0 1 1 if the firm regulates the use of temporary rotation practices through 
either collective contracts or other internal negotiations; 0 otherwise  
Control Variables 
modern_practice 0 1 1 if the firm reports the use of total quality management and/or just-in-
time organizational practices irrespective of actual importance; 0 
otherwise 
large_sme 1 2 Size of the firm 1=Large, 2=Medium, small and micro 
expt_largesme 0 2 Firms classified by exporting behaviour and size. Interaction term 
between export_dummy and large_sme; 1=large, 2=small and medium 
sized (SME), 0 no participation in export markets 
fdi_largesme 0 2 Firms classified by size and foreign ownership. Interaction term between 
foreign_share and large_sme: 1=large, 2=SME, 0 no participation of 
foreign capital in total social capital of the firm 
Notes: Information for the 112 data points in working sample; * Thousand Mexican pesos; variables in bold are those created by the 
authors with information from the source 
Source: ENESTYC, 2005; INEGI, Mexico 
 
 
Table 2 presents the explanatory and control variables in this paper. Boseli et al, (2005:74) 
acknowledge three forms to measure human resource management variables: “by its presence 
(that is, a dichotomous scale for whether it is actually in effect 'yes' or 'no'), by its coverage (that 
is, a continuous scale for the proportion of the workforce covered by it) or by its intensity (that 
is, a continuous scale for the degree to which an individual employee is exposed to the practice 
or policy). The overwhelming majority [of studies] rely only on measures of presence.” In 
general, this is the case with ENESTYC. Only a few variables reflect intensity in management 
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practices. For example, the indicator on workers’ participation in decision-making shows the 
perceived importance of the practice by the employer. Wright and Boswell (2002) and Boseli et 
al. (2005) advise caution on differences in measuring management variables in terms of either 
policies or practices. Whereas the former reflect an organization's stated intentions regarding 
management activities, the latter are the actual, functioning, observable activities, as 
experienced by employees. Written policies will influence performance only if individuals 
perceive them as important for organizational well-being. ENESTYC contains several variables 
representing regulations on management practices. Detailed information on how such rules 
translate into actual practice is missing. Consequently, great care was taken when introducing 
them in the analysis. 
 
4.2.1. Control variables 
 
Lundvall and Valeyre (2007) in the case of Europe, OECD (1998) for the OECD countries and 
Kaplinsky (1995) for developing countries document the interrelation between modern 
management practices and organizational strategies adopted by firms. Such strategies 
correspond with the type of management practices available for firms, and shape the 
environment in which learning takes place (Arundel et al., 2007). In the case of pharmaceutical 
firms, and in the context of cGMPs, TQM practices assist in meeting the strict quality controls 
required by regulatory authorities. In this study, the variable modern_practice controls for the 
use of JIT and/or TQM practices. Capital origin and export behaviour reflect the technological 
performance of pharmaceutical firms in developing countries such as Mexico (Kim et al., 1989; 
Zúñiga et al., 2007). By normalizing the variables on export exposure and capital origin with 
respect to firms' size it was possible to correct problems of high and positive correlations among 
some variables on the right hand side of the equation. It also captured the scale effects 
(Cockburn and Henderson, 2001). 
 
4.3. Research strategy 
 
The dependent variables in this section denote the likelihood that a pharmaceutical firm carries 
out in-house R&D. A suitable approach for studying this type of decision variables is a 
probability model, such as binary probit regression (Liao 1994; Greene 2003). The dependent 








The linkage function between the vector of dependent variables Y and the explanatory variables 
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Given the binary nature of Y, one can express the linkage function between Y and xi in a more 
general fashion as η . A probit model is a generalised linear model with a probit link: 
 
 
µη 1−Φ=         (3) 
 
Where Φ  is the standard normal cumulative density function (CDF) in the form of a 
standardized variable, Z score, expressed in probability terms (Liao 1994). Probit analysis 
assumes binomial distribution of the dependent variable and normal distribution in the errors 
term, ε .5  
 
The analysis proceeded as follows: some basic model specifications based on statistical 
significance and theoretical consistency were identified. To minimize potential multicolinearity 
problems, combinations of variables with correlations equal or larger than 5.0±  were avoided 
(Annex 1). Accordingly, the provision of training, the log of average monthly remuneration, and 
the importance of worker’s participation in decision-making processes were retained. As for the 
variables on formal regulations to govern temporary rotation, procedures to hire new staff and 
staff promotion, they were merged to correct for their positive correlations in excess of 0.56. The 
new variable, "rules_hrm", runs from 0-3 depending on the number of practices regulated by the 
firm7. Additional models tested adequacy of variables on modern organizational practices. The 
variable on just-in-time was highly correlated with other indicators such as worker’s 
participation in decision-making, use of temporary rotation assignments and so on. The use of 
modern_practice, indicating simultaneous adoption of TQM or JIT by the firm, helped to 
overcome these problems. Alternative models including only the TQM variable rendered similar 
results to those presented here. 
 
Analysis started by exploring the extent to which control and management practices explain the 
likelihood that a firm performs in-house R&D. Then, the definition of the dependent variable 
was iteratively changed, while keeping the basic structure at the right hand side of the equation 
unchanged. Note a minor difference in the definition of training used in models with 
rd_design_meq as the dependent variable. The majority of firms reported to have provided 
training to employees during 2004. Consequently, models with train04 had problems 
converging; the variable predicted the probability that a firm performs such type of R&D. The 
choice was for the alternative, internal_external_tr, which denotes interactions between internal 
and external training. Individual effects of internal and external training, respectively, were 
tested on the remaining definitions of R&D. Several checks were performed to ensure accuracy 
and robustness of results. Models were included, where each of dependent variable was 
regressed on the control variables only. Thus it was possible to observe the extent to which 
control variables explain the learning behaviour of pharmaceutical firms. Equations were then 
run, including only those explanatory and control variables that reveal some statistical 
                                                 
5 An alternative is logit regression analysis where the errors term, ε  would assume a logistic distribution. 
In general, probit and logit render similar results (Greene 2003).  
6 Factor analysis showed that the three practices on the regulation of management practices show a 
tendency to cluster independently from the other management variables in the equation. 
7 The rules_hrm were computed based on both exploratory factor analysis and the arithmetic mean of the 
three original variables: rules_hrm=(rule_promotion+rule_hiring+rule_temprotation)/3. In either case, 
results were similar to those reported here. For simplicity of the analysis the index variable was retained. 
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significance, at 5 per cent or less, in the basic model. For reasons of space and feasibility of the 
analysis, results from those models are included but, in all cases, estimations corroborated 
robust results. 
 
5. Empirical results  
 
5.1. Learning behaviour of pharmaceutical firms in Mexico 
 
Annex 2 summarizes the learning behaviour of pharmaceutical firms in Mexico. Some 74.1 per 
cent of firms performed R&D in 2004, with some 63.4 per cent and 70.5 per cent focusing on 
process and product innovations, respectively. Of those performing R&D for process 
innovation, 25.3 per cent did so to improve or design machinery for their own use, while some 
63.4 per cent to improve productive processes. As for demand-enhancing innovations, some 
61.1 per cent of firms pursued new products, and some 66.1 per cent focused on improvements 
in existing drugs. In this context, indicators such as sales and employment show that, on 
average, R&D performers slightly outperform those reporting no R&D activities. For instance, 
average employment, total sales and sales per employee are, respectively, 1.4, 1.6 and 1.1 times 
larger in firms with active learning strategies. By contrast, indicators on capital origin and 
export orientation tend to favour non-R&D performers. Some 70 per cent of firms carried out 
either knowledge exploitation or exploration. The corresponding figures on employment, sales 
and so on, are very close among each group, yet with a slight advantage for active learners. A 
significant number of firms participate in external markets. However, since the average share of 
exports in total sales of the industry is rather modest, one could argue that pharmaceutical firms 
are strongly oriented to serving the local market. In line with the cGMP’s requirement, 
ENESTYC reports an extensive adoption of modern manufacturing practices in the 
pharmaceutical industry. 
 
5.2. Learning through in-house R&D 
 
Table 3 presents estimates from the econometric analysis. Model (1) corresponds to in-house 
R&D, irrespective of the goal pursued by the firm. Models (2) and (3) include  cost-reducing 
R&D, while models (4) and (5) relate to demand-enhancing R&D. As can be seen the table is 
split in two sections; models with control variables only, and those with the full set of 
explanatory and control variables. Liao (1994) and Long and Freese (2006) suggest that rather 
than maximizing the value of any specific scalar measure of goodness of fit, the analysis should 
be consistent with theory and previous research. The Wald tests for the value of X2, which is 
different from zero, confirm that the models are statistically significant at standard confidence 
levels. The classification table of observed and predicted values, cutting point at 0.5, show that, 
in general, the predictive power of each model is acceptable (Liao 1994). For instance, in model 
(1) 100 positive cases were predicted, with 78 of them correctly classified because the actual 
observation corresponded with an R&D performer, (y=1). The remaining 22 cases were 
incorrectly assigned because the actual observation was a negative response, (y=0). Conversely, 
out of 12 responses predicted as negative, 7 were correct and 5 incorrectly classified. The values 




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Individual estimates reveal that training has the strongest and most significant effect on 
learning. It also increases the likelihood that firms carry out R&D. Remunerations are important 
for new process- and new product-related R&D. Workers' empowerment has positive and 
statistically significant effects on knowledge exploration. The regulation of some management 
practices, rules_hrm, is relevant only for rd_design, albeit with negative effects. Contrary to 
expectations, the control variables have little influence on R&D performance. The exception is 
knowledge exploration which supports new drug design. Exports and capital ownership play 
relevant roles. The effects, however, run in opposite directions. Whereas export participation 
induces learning, foreign ownership inhibits it. Scale effects are also captured as the two latter 
variables are normalized by the firm's size. Adoption of modern_practice does not reveal any 
specific effect on learning. Overall, the estimates suggest a passive learning behaviour of the 
pharmaceutical industry in Mexico. The constant term is consistently negative and statistically 
significant. If all right-hand side coefficients were set at zero, the probability that a 
pharmaceutical firm carries out R&D is rather low. 
 
A complementary way to look at results in table 3 is by computing the marginal effects derived 
from modifications in the value of a given explanatory variable. These are changes in the 
likelihood of observing a given outcome contingent on changes in the value of an explanatory 
variable. In this regard, nonlinearities imply that shifts in probabilities depend on two combined 
effects: On the one hand, the actual change in the variable of interest and, on the other, the 
values adopted by the remaining elements in the equation. The latter are assumed to remain 
constant, usually, at the mean value. Comparisons are made relative to specific characteristics of 
the issue under investigation. For binary variables, the only relevant change in probabilities is 
the shift from 0 to 1, and vice versa (Long and Freese 2006). This can be interpreted as going 
from absence to adoption of a particular management practice. By contrast, changes in 
continuous variables can be evaluated in different magnitudes, such as standard deviations or, 
directly, in percentages (Christofides et al. 1997; Christofides et al. 2000). 
 
There are two alternative ways to compute probability changes (Long and Freese 2006). One 
option is to compute marginal effects on specific outcomes of the dependent variable. An 
advantage of this approach is that it provides the direct marginal rate of change to which 
economist are used to. This is together with estimates of standard errors and statistical 
significance of observed effects. Alternatively, one can compute probability changes in terms of 
discrete movements in a given explanatory variable. This requires defining two numbers: the 
amount of change in the examined indicator, and the values assumed for all remaining variables 
in the model. Table 4 presents the marginal and discrete probability changes associated to 
models in Table 3. The very last column in Table 4 contains computation of marginal rates of 
change. They confirm that training has the largest positive and statistically significant impacts 
on the likelihood that a firm performs R&D. The shift from non- to provision of training raises, 
by some 51 percent, the probability that a firm carries out R&D. An effect of similar magnitude 
is exerted on the likelihood that such R&D looks for new drug designs. The lowest influence, 
some 10 percent, is found in the case of rd_design_meq.  
 
Table 4 corroborates that the influence of management practices on learning is more 
pronounced in the case of rd_design. Marginal increases in remunerations have a positive 
impact on learning. The exception is rd_impr_proc. By contrast, one can confirm the negative 
impact of rules_hrm on rd_drug_design. Interpretation of discrete probability changes should be 
handled with care, they are meaningful only for variables spanning over a sufficiently large 
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range of values (Long and Freese 2006). A pertinent case is that of remunerations. Column (1) 
in table 4 reveals that a change in the logarithm of remunerations, equivalent to an increase from 
minimum to maximum, raises the likelihood that a firm conducts rd_drug_design by some 0.54. 
The effects of changes in remunerations are stronger for demand-enhancing R&D than for cost- 
reducing activities. The impact from changes of half a standard deviation in the log of 
remunerations, column (4), are larger for rd_design than any other type of process R&D. 
 
 














train04 0.51 0.51 0.4 0.13 0.42 0.51**
ln_avg_rem 0.42 0.08 0.15 0.1 0.15 0.15*
imp_empowerment 0.15 0.09 0.08 0.07 0.08 0.08
rules_hrm -0.07 -0.07 -0.07 -0.03 -0.07 -0.07
modern_practice -0.05 -0.05 -0.05 -0.02 -0.05 -0.05
expt_largesme 0.19 0.11 0.1 0.08 0.1 0.1
fdi_largesme -0.5 -0.22 -0.21 -0.14 -0.21 -0.21
rd_impr_proc      0.650
train04 0.41 0.41 0.39 0.12 0.4 0.41***
ln_avg_rem 0.33 0.08 0.12 0.08 0.12 0.12
imp_empowerment 0.21 0.11 0.11 0.09 0.11 0.11*
rules_hrm 0.03 0.03 0.03 0.01 0.03 0.03
modern_practice 0.04 0.04 0.04 0.02 0.04 0.04
expt_largesme 0.04 0.02 0.02 0.02 0.02 0.02
fdi_largesme -0.34 -0.16 -0.16 -0.11 -0.16 -0.16**
rd_design_meq  0.101
Internal_external_tr 0.18 0.02 0.1 0.1 0.1 0.10***
ln_avg_rem 0.27 0 0.11 0.07 0.11 0.11**
imp_empowerment 0.35 0.11 0.13 0.11 0.13 0.13***
rules_hrm 0.06 0.06 0.06 0.03 0.06 0.06
modern_practice -0.11 -0.11 -0.1 -0.05 -0.1 -0.11
expt_largesme -0.06 -0.04 -0.03 -0.03 -0.03 -0.03
fdi_largesme -0.17 -0.14 -0.15 -0.1 -0.15 -0.15**
rd_drug_imp  0.674
train04 0.38 0.38 0.34 0.11 0.36 0.38**
ln_avg_rem 0.53 0.04 0.2 0.13 0.2 0.20**
imp_empowerment 0.12 0.06 0.06 0.06 0.06 0.06
rules_hrm 0.06 0.06 0.06 0.02 0.06 0.06
modern_practice -0.07 -0.07 -0.07 -0.03 -0.07 -0.07
expt_largesme 0.03 0.01 0.01 0.01 0.01 0.01
fdi_largesme -0.36 -0.17 -0.17 -0.11 -0.17 -0.17
rd_design      0.667
train04 0.51 0.51 0.48 0.16 0.51 0.51***
ln_avg_rem 0.54 0.03 0.2 0.14 0.2 0.20**
imp_empowerment 0.26 0.15 0.14 0.12 0.14 0.14**
rules_hrm -0.24 -0.24 -0.24 -0.1 -0.24 -0.24**
modern_practice 0 0 0 0 0 0
expt_largesme 0.37 0.21 0.2 0.17 0.2 0.20***
fdi_largesme -0.68 -0.37 -0.36 -0.24 -0.37 -0.37***
Min->Max: change in predicted probability as x changes from minimum to maximum; 0->1: change in predicted probability as x changes 
from 0 to 1; -+1/2: change in predicted probability as x changes from 1/2 unit below base value to 1/2 unit above; -+sd/2: change in 
predicted probability as x changes from 1/2 standard deviation below base to 1/2 standard deviation above; MargEfct: partial derivative of 
the predicted probability/rate with respect to a given independent variable. 1. Computed based on the method of discrete changes; 2. 
Computed based on the method of marginal changes; robust standard errors in parentheses; ***,**,* denote significance at the 1%, 5% 





So far, the analysis has considered some detailed definitions of the R&D variable. Thus it was 
observed that management practices distinctly affect learning through R&D. Here, two major 
patterns were identified. First, in line with the notion of exploitation and exploration, the most 
significant effects are associated with knowledge exploration, whether for new processes or 
product innovations. The more explorative the search, the stronger the exigency on the human 
resources. Second, table 4 underlines some differentiated influence of management practice on 
R&D for either process or product innovations. For reasons of space and pertinence of the 
analysis, in what follows concentration is on the first observed pattern. 
 
5.2.1. R&D for knowledge exploitation or exploration  
 
Human resources, a core ingredient of a firm’s resource base, are expected to contribute 
differently to learning and innovation depending on the knowledge involved in such activities8. 
Nelson and Winter (1982) and Fransman and King (1984) argue that, over time, firms gain 
experience and, eventually, develop routines that increase their efficiency and productivity in 
manufacturing and, in general, the management of current product portfolios. Improvements in 
products, processes or both are generally based on searches within a firm’s accumulated 
knowledge. Conversely, the more alien the intended innovation relative to what the firm knows, 
the larger the need to look beyond familiar cognitive boundaries. Management systems 
influence and play a mediatory role in these processes via the creation, transfer and integration 
of knowledge flows that enrich a firms’ human capital, as a stock (Wright et al., 2001), in ways 
that are valuable, rare and inimitable (Grant, 1996).  
 
So far the findings here suggest that management practices are associated more with knowledge 
exploration than with other activities. These findings were investigated further by running two 
additional models on two dummy variables. First, R&D for knowledge exploitation (rd_exploit) 
and second, R&D for knowledge exploration (rd_explore). Results are presented in table 5. 
Similar to table 3, it includes two specifications. First, models with control variables only, then 
those with the full set of variables. Table 5 confirms the expected differences in the contribution 
of management practices to exploration and exploitation strategies. Knowledge exploration, in 
the sense of research, experimentation and technological capability-building, is associated with 
stronger exigencies on management practices. The provision of training, remunerations and 
worker’s empowerment have positive and statistically significant effects. Exports and the origin 
of capital ownership, controlled by size of the firm, report significant, yet opposed effects on 
knowledge exploration. Table 5 includes the computation of marginal effects. In general, they 
confirm that the effects of management variables are much stronger for R&D for knowledge 
exploration. 
 
                                                 
8 To some extent such differences result from the distinct nature of innovation across industrial sectors 




Table 5: Influence of management practices on knowledge exploitation and exploration by pharmaceutical 
firms in Mexico 
Variables rd_exploit rd_explore 
   Mg effect   Mg effect 
train04  1.25*** .465***  1.48*** 0.53*** 
  (0.44) (0.16)  (0.50) (0.14) 
ln_avg_rem  0.44* 0.14*  0.55** 0.20** 
  (0.24) (0.08)  (0.25) (0.09) 
imp_empowerment  0.24 0.08  0.45** 0.16** 
  (0.17) (0.06)  (0.19) (0.07) 
rules_hrm  0.07 0.02  -0.66* -0.24* 
  (0.35) (0.11)  (0.34) (0.12) 
modern_practice 0.22 -0.25 -0.08 0.41 -0.15 -0.05 
 (0.27) (0.33) (0.10) (0.27) (0.33) 0.12 
expt_largesme 0.30 0.17 0.06 0.59*** 0.54** 0.19** 
 (0.19) (0.21) (0.07) (0.20) (0.23) (0.08) 
fdi_largesme -0.43* -0.64*** -0.21*** -0.68*** -1.04*** -0.37*** 
 (0.22) (0.24) (0.08) (0.25) (0.27) (0.10) 
Constant 0.39 -2.46**  -0.073 -3.34***  
 (0.24) (1.11)  (0.23) (1.20)  
Observations 112 
Log Likelihood Full -64.6 -57.6  -67.2 -57.1  
Χ2 [3]4.66 [7]20.3***  [3]12.7*** [7]29.6***  
Cragg-Uhler R2 ---- 0.221  ---- 0.358  
Count R2  0.72   0.70  
Notes: Robust standard errors in parentheses, *** p<0.01, ** p<0.05, * p<0.1; Degrees of freedom within squared brackets 
 
 
5.3. Investigating the effects from different types of training  
 
So far the provision of training revealed a positive and robust influence on the likelihood that a 
firm performs R&D. This is consistent with the literature on human capital development and 
some previous studies on innovation and human resource management (Michie and Sheehan 
1999, 2003). In order to extract some more meaningful conclusions, more disaggregated 
measures on the actual nature of training were introduced. Section 3.2 identified two 
complementary forms: internal (on-the-job) and external (off-the-job). The former was expected 
to support knowledge diffusion and sharing within the organization, as it would be more closely 
related to exploitation strategies. By contrast, external training would generaly support the 
expansion and enrichment of knowledge bases through interaction with other knowledge 
producers (Casas 2005).  
 
Two additional variables, namely, training_internal and external_training captured the dual 
nature of training. The analysis excluded models with rd_design_meq because training_internal 
tended to predict perfectly the probability of a firm performing this specific type of R&D9. 
                                                 
9 In the presence of perfect prediction STATA drops the problematic variables out from the equation. An 
option was to use an interaction term, internal_external_tr, capturing the simultaneous provision of 
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Table 6 contains estimates for models with the alternative definitions on training. The Wald 
tests show that, with the exception of rd_drug_improvement, the remaining models are 
statistically significant at conventional confidence levels. Estimates confirm that internal 
training is more closely related to knowledge exploitation, while that provided by external 
agents impacts more directly on exploration, particularly rd_design. Management interventions 
is confirmed to have a very strong influence on exploration-like R&D. However, it is somewhat 
surprising to see the significance of remunerations deteriorating while, at the same time, 
worker’s empowerment gains prominence. The models corroborate the negative impact of 
rules_hrm on learning. Finally, export participation appears to stimulate learning, particularly 
for (new) product innovation. 
 
 
Table 6: Testing the influence of internal and external training on performance of in-house R&D 
Variables rd_inhouse rd_exploitrd_explore rd_improve_processrd_drug_design rd_drug_improvement 
training_internal 0.68** 0.73** 0.64* 0.64** 0.56* 0.41 
 (0.33) (0.32) (0.34) (0.33) (0.34) (0.31) 
external_training 0.53* 0.37 0.83*** 0.43 0.78** 0.29 
 (0.31) (0.31) (0.31) (0.31) (0.31) (0.30) 
ln_avg_rem 0.37 0.34 0.41 0.23 0.42* 0.47** 
 (0.25) (0.24) (0.25) (0.23) (0.24) (0.24) 
imp_empowerment 0.31* 0.27 0.50*** 0.32** 0.43** 0.18 
 (0.18) (0.17) (0.19) (0.16) (0.19) (0.17) 
rules_hrm -0.21 0.05 -0.70** 0.05 -0.68** 0.19 
 (0.36) (0.34) (0.35) (0.32) (0.35) (0.33) 
modern_practice -0.07 -0.18 -0.12 0.15 0.03 -0.12 
 (0.33) (0.32) (0.32) (0.31) (0.32) (0.30) 
expt_largesme 0.38* 0.19 0.61*** 0.06 0.62*** 0.05 
 (0.21) (0.21) (0.21) (0.19) (0.21) (0.19) 
fdi_largesme -0.70*** -0.63** -1.06*** -0.42* -1.02*** -0.44* 
 (0.24) (0.25) (0.26) (0.23) (0.26) (0.23) 
Constant -1.95* -1.77* -2.53** -1.71* -2.61** -2.31** 
 (1.12) (1.07) (1.09) (0.99) (1.07) (1.04) 
Observations 112 
Log Likelihood Full -53.5 -58.0 -56.0 -64.7 -57.0 -64.8 
Χ2 [8] 26.9*** 20.8*** 38.0*** 19.7** 37.9*** 13.7* 
Cragg-Uhler R2 0.25 0.21 0.38 0.20 0.37 0.16 
Count R2 0.79 0.75 0.74 0.70 0.73 0.73 





This paper investigated the influence of management practices on the likelihood that a firm 
performs in-house R&D. Firms could choose between two alternatives, not necessarily mutually 
exclusive, learning strategies. In the context of the pharmaceutical industry, firms may tap their 
accumulated knowledge base and perform some imitative R&D. This underpins the 
manufacture of generic drugs according to well established parameters set by the drug 
innovator. Alternatively, firms may perform more formal R&D activities and seek to 
incorporate some significant improvements in the quality of products. Looking at distinct R&D 
                                                                                                                                               
internal and external training. In the interest of space and consistency of the analysis we omit them from 
presentation; however, results for the rest of models were similar to those reported here. 
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outcomes with diverging degrees of novelty, some positive linkages between management 
practices and learning at firm level were found. More specifically, the influence from such 
practices was  stronger as the novelty of the knowledge required increased. The variable new 
drug design revealed more interesting results. This supports previous studies on new product 
development. Management practices stimulate creativity, risk-taking and exploration; they assist 
in channelling and increasing knowledge and skills of the personnel involved (Lund 2004a). In 
this context, although some evidence is provided on the impact of management practices on 
R&D for process innovation, further research is needed to extract more concrete conclusions. 
This is relevant considering that process innovations enjoy a significant share of innovations in 
developing countries. 
 
With regard to specific personnel management interventions, comments are as follows. 
Referring to the hypotheses presented in section 3.2.1, some results for specific management 
variables can be highlighted. The provision of training systematically exerts positive effects on 
the likelihood that a firm pursues R&D. This supports Domínguez and Brown (1998)’s and 
Samstad and Pipkin (2005)’s perception that training and general qualifications of the labour 
force dictate the type of management practices needed and feasible in countries such as Mexico. 
Raising skill levels facilitates the adoption of advanced management systems in Mexican firms. 
A similar conclusion can be drawn for workers’ empowerment, the practice was positive 
particularly with regard exploration-related R&D. This is consistent with previous literature. 
Delegation of decision-making capacity and trying new things is key for new product 
development, it fosters creativity and discovery (Mumford 2000). The finding also confronts the 
perception that paternalistic work environments, rigid and hierarchical structures are unsuitable 
for enhanced performance. Kim and Cha (2000) and Bae and Rowley (2004) state that research 
on organizational practices and R&D in developing countries needs be addressed in a more 
critical manner. It needs to consider the contexts where such practices occur more carefully. 
According to Dávila and Elvira (2007) distinct environments lead to distinct relationships of 
mutual obligation---supervisor-employees. There is no reason for such differences, relative to 
more advanced counties, to impact negatively on firms’ performance. 
 
Also some limits to the influence of workers’ empowerment on R&D should be recognized. The 
practice was not significant for knowledge exploitation. Further research is needed to extract 
more concrete conclusions. Yet one may speculate these results from the nature of drug 
manufacturing processes. Concerns over product quality and safety lead to close scrutiny and 
approval by sanitary authorities thereby limiting the capacity to change the processes. It may 
require additional reviews and approval by the regulatory authorities. FDA (2004a, b) 
recognizes that this can be cumbersome for the firm; it reduces the scope for process innovation 
in the pharmaceutical industry. Development of generic drugs is restricted by the need to 
comply with specific parameters set by the drug innovator. If firms are required only to 
reproduce the knowledge behind such products, it makes little sense to allow workers to play 
around with the technology. 
 
The literature review here suggests that remunerations would influence learning positively. 
Estimates reveal that raising remunerations increases the probabilities that a firm performs 
R&D. However, the effect was not robust. It loses significance in models distinguishing 
between internal and external training. Albeit difficult to corroborate based on data used here, a 
possible explanation results from the frequent mark-up on pecuniary remunerations, more 
specifically wages, in countries such as Mexico. Factors such as enhanced training and/or 
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promotion opportunities may be equally or even more relevant as reward mechanisms. 
Remunerations would underpin learning but only under certain conditions and for specific types 
of R&D, namely, knowledge exploration. 
 
Equally intriguing was the finding that regulations on practices, such as staff recruitment, staff 
promotion or temporary rotation, failed to provide conclusive results. This could reflect the gap 
between discourse and practice in management approaches in Latin America. Managerial issues 
are quoted as a key ingredient for success; yet, implementation would be fragmented and lack 
consistency with stated principles. Considering the limited information at hand, it is difficult to 
corroborate this hypothesis. The exploratory evidence here suggests other possible lines for 
research. For instance, no matter how well defined policies to hire new staff may be, the 
Mexican market for R&D professionals remains rigid. It is hard to find people with sufficient 
knowledge and experience in pharmaceutical research. This includes advanced and applied 
research techniques aligned with drug manufacturing and design. Even PhD holders would find 
it unattractive to work for local generic firms, as publishing perspectives would be limited. 
Firms, in turn, may be unable to fulfil the researchers’ economic and professional expectations. 
Similar to the Indian experience (Kale and Little 2007), some corrective strategies include the 
search for talent abroad. However, such practice is limited to a few Mexican firms. 
 
Considering staff promotion, at first sight the results here seem intriguing. Particularly among 
multinational affiliates, great concerns are placed on personnel and career development plans, 
on designing precise succession strategies. This notwithstanding, since R&D activities in those 
firms are limited, opportunities to pursue R&D careers are scarce. In the case of Mexican firms, 
properly designed plans for staff promotion focus exclusively on small groups of “talented 
people”. This may induce some negative incentives for people outside such groups. In the case 
of rotation assignments, the expected positive influence on knowledge sharing and diffusion 
could not be confirmed. Staff rotation may serve very different purposes, but this needs further 
work in the future. Abramo (1997) points out that staff rotation may help to minimize burn-out 
and other negative effects associated with highly routined and repetitive jobs. In some Mexican 
generic manufacturing firms, rotation assignments implied temporary transfers of personnel, 
from the development unit, for instance, to supporting manufacturing or quality control 
activities. R&D subrdinates to the requirements of daily manufacturing operations. 
 
The findings here contradict the usual perception that foreign firms are more technologically 
dynamic than domestic firms. The choice of performance indicators is very important. In terms 
of R&D, a careful reflection points to the position that countries, such as Mexico, occupy within 
business and innovation strategies of multinationals. Local affiliates maintain a low profile 
when assisting in the exploitation of knowledge generated at the parent location or elsewhere in 
the developed world (von Zedtwitz and Gassmann 2002). Acquisition of new knowledge, 
demanding R&D activities, is seldom carried out in developing countries. By contrast, exposure 
to external competition and larger market opportunities was found to increase the likelihood that 
a firm pursues R&D. The strongest effect was associated with new drug designs. In line with 
Kale and Little’s (2007)’s findings, the managing director of an affiliate of Indian origin argued 
that “Success requires strong commitment of financial and human resources, particularly in 
research. The goal is to develop a portfolio of products to be launched in export markets over a 
significant time horizon”. In the case of the Mexican industry, strong reliance on the local 
pharmaceutical market may inhibit incentives to innovate; management strategies would aim to 
increase productivity and efficiency. In other words, adoption of modern organizational 
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Establishing a consistent theory on the relationship between human resource management 
practices and innovation performance at firm level is at an early stage, since the linkages 
between those variables are yet to be comprehended. This paper provides some evidence that 
management practices influence innovation by stipulating, first, learning and capacity-building 
through in-house R&D. This is one of the first systematic analyses of the influence of human 
resource management over learning through R&D in developing countries. Focus on the 
Mexican pharmaceutical industry illustrates the importance of carefully considering the contexts 
in which management practices work. Overall macroeconomic conditions and the social 
environment around R&D dictate not only what is possible and feasible but also what can be 
expected from management interventions. No matter how advanced, a well trained and 
experienced labour force may be, it will generate positive results in terms of innovation only if 
it is consciously provided with opportunities to do so. The effects of management practices on 
performance may depend on how countries get involved and contribute to innovation in specific 
industries. Learning mechanisms differ among firms and countries. 
 
Pharmaceuticals are highly R&D intensive. The capacity to perform R&D determines the 
viability and capacity of a firm to grow in the market. In a catching-up context, R&D is 
intertwined with the capacity to exploit and explore technological and market opportunities. At 
a basic level of technlogical capabilities, R&D supports the accumulation of some knowledge 
and experience needed to progressively introduce more sophisticated drugs into the market. 
Recent experiences in India support this argument. In addition, sectoral differences in the nature 
of R&D lead to distinct knowledge requirements and consequently, demands on human 
resources.  
 
From a methodological perspective, the paper shows the benefits of pursuing research on 
management practices and innovation. A more careful investigation of the latent processes 
involved, in this case learning, is necessary. This is already a familiar approach for management 
scholars interested in understanding how management practices affect creativity and creative 
thinking. This type of approach could pave the way towards understanding how human factors 
and their organization inside firms could contribute to the building and operation of systems of 
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